Bixiye
P56-17 Implementation of a Medical Drug Exclusions List
Taariikhda uu dhaqangalayo barnaamijka: Okt 16, 2017
Natiijooyinka Raadinta
Soo bandhiga 3281 - 3290 ee natiijooyinka 3688
Bixiye
P5R1-17 Updated: Third Party Payments of Premium and/or Cost-Sharing
Taariikhda dhaqangalka Barnaamijka: Jul 05, 2017
Bixiye
P14-16 Addition of Lazanda ® to Existing Drug-Related Prior Authorization with Quantity Limit Program
Taariikhda uu dhaqangalayo Barnaamijka: Mar 29, 2016
Bixiye
P49-16 New Drug-Related Prior Authorization Criteria with Quantity Limit for Zavesca
Taariikhda uu dhaqangalayo barnaamijka: Okt 27, 2016
Bixiye
P24-16 Providers will see a change in our Prior Authorization Process for Government Products
Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2016
Bixiye
P15-16 Place of Service 53 will be Changed to a Facility Place of Service
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 07, 2016
Bixiye
P20-16 Addition of Uptravi ® and Adempas ® to Existing Drug-Related Prior Authorization Program
Taariikhda uu dhaqangalayo Barnaamijka: May 04, 2016
Bixiye
P10-16 New Drug-Related Prior Authorization Criteria for Gattex
Taariikhda uu dhaqangalayo Barnaamijka: 08, Feb 2016
Bixiye
P50-17 Provider Data Accuracy and Identified Lack of Claim Submissions
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 25, 2017
Bixiye
P30-16 New Prior Authorization Requirement for Lyme Disease: Diagnostic Testing and Intravenous Antibiotic Therapy
Taariikhda dhaqangalka Barnaamijka: Jul 07, 2016